The question is not whether reproducibility is good, it's how much labs should invest upfront in producing descriptions of protocols. My argument is that they s

The question is not whether reproducibility is good, it's how much labs should invest upfront in producing descriptions of protocols. My argument is that they should probably invest more than they do now, but not enough that pharmacutical companies are able to reproduce a given experiment without talking to the lab. Science is a collaborative process. There's nothing wrong with collaboration being part of the reproducibility process, as long as the person doing the reproduction maintains their objectivity.